United States Senator Tina Smith (D-Minn.) reintroduced legislation this week, to hold insulin manufacturers accountable for excessive increases in the price of life-sustaining insulin.
United States Senator Tina Smith (D-Minn.) reintroduced legislation this week, to hold insulin manufacturers accountable for excessive increases in the price of life-sustaining insulin.
I encourage the House to pass a strong PDAB bill without amendments, so that we have a new tool to save Minnesotans’ money and lives and protect all Minnesotans from Big Pharma’s abuses.